(AMPH) |
| 0 (0%) 10-10 18:21 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 29.43 |
| Resistance 1: | 27.05 |
| Pivot price: | 26.41 |
| Support 1: | 23.19 |
| Support 2: | 19.30 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 2.670 |
| Book Value | 16.290 |
| PEG Ratio | 0.00 |
| Gross Profit | 7.749 |
| Profit Margin (%) | 18.64 |
| Operating Margin (%) | 24.19 |
| Return on Assets (ttm) | 7.3 |
| Return on Equity (ttm) | 18.3 |
Company news
Thu, 09 Oct 2025
BofA Securities Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $31 - 富途牛牛
Thu, 09 Oct 2025
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Benzinga
Tue, 07 Oct 2025
3 Stocks Under $50 We’re Skeptical Of - TradingView
Fri, 26 Sep 2025
CX Institutional Has $6.05 Million Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Tue, 23 Sep 2025
After Protracted Sell-Off, Amphastar Looks Like A Value Pick (NASDAQ:AMPH) - Seeking Alpha
Tue, 16 Sep 2025
Amphastar Pharmaceuticals, Inc. (AMPH) Secures FDA Approval for Generic Iron Sucrose Injection - MSN
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
